I wanted to talk about hepatitis B -- Firstly, this is a great review article and so is this.
Secondly - Serologies:
- Early in infection you have the production of Hepatitis B Surface Antigen and Hepatitis B Envelope Antigen which represents active infection
- The you develop hepatitis B core IgM then core IgG. These antibodies are not protective
- If you are going to clear your infection you will next develop anti-hepatitis B-EAg antibodies, clear your E antigen and then start to clear your S-Antigen
- You then make hepatitis B surface antibodies
- There can be a window period in between clearing the S-Ag and developing the anti-HepB surface antibody where the only way you will know if they are infected is by the core antibody.
A natural, but cleared infection will have positive HepB surface antibody and core antibody and no surface antigen
A patient with chronic active hepatitis will have core antibody and in most cases hepatitis B surface antigen. They may also have E antigen (or E antibody). They will not have surface antibody.
For chronic carriers treatment depends on a number of factors -- this table provides an excellent summary:
Note that I link to a lot of NEJM articles. This is my preferred journal. Those of you with a U of T library account have NEJM access via e-journal search in the gerstein library website. We pay for an institutional license @ U of T which you can access at home and there is a licence here at the hospital.
Those of you who would like their own subscription (b/c above don't work) can obtain one here ($~60/year for electronic only ~ $150 for print copy too)